Biotech entity
Every one of those 1 sits in a single category, pharma. Healthcare sector is most often covered alongside Financial Sector, which appears in 1 of these 1 story. Their average consequence score of 6 runs below the beat's 6.3 for that window.
Last mentioned: Aug 24, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Healthcare sector is most often covered alongside Financial Sector, which appears in 1 of these 1 story. Their average consequence score of 6 runs below the beat's 6.3 for that window. Source depth averages 3 original sources per story, versus 3.3 across the same-window beat baseline. Healthcare sector appears in 1 tracked Biotech story from March 17, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Healthcare sector. Shared-story counts are live from our verified record — not editorial picks.
Geopolitical instability in the Middle East has triggered a sharp sell-off in mid-cap healthcare equities, pushing several key players into technically 'oversold' territory. This volatility presents a potential entry point for value-oriented investors as Relative Strength Index (RSI) levels for the sector hit multi-month lows.
Healthcare sector is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
